IP Library Granted Patent US 10,688,118
Granted Patent B2
US 10,688,118 · App. 15/033,285 · Granted Jun 23, 2020

Nicotinamide riboside compositions for topical use in treating skin conditions

Inventors: Ann Deren-Lewis (Irvine, CA); Troy Rhonemus (Irvine, CA)
Assignee: ChromaDex Inc.
A61K31/706
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,688,118
App. No.
15/033,285
Granted
Jun 23, 2020
Kind
B2
Abstract

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

Claims (6)

1. A method for repairing a wound in the skin of an individual, comprising topically administering to the individual in need of such treatment over at least about 24 hours, or more, a therapeutically effective amount of the compound nicotinamide riboside, or a salt thereof, wherein skin cells in the skin have increased motility effecting wound repair.

2. The method of claim 1 , wherein the individual is a human.

3. The method of claim 2 , wherein the nicotinamide riboside compound, or a salt thereof, is provided in a composition comprising a pharmaceutically acceptable carrier.

4. The method of claim 3 , wherein the nicotinamide riboside compound is a salt selected from the group consisting of fluoride, chloride, bromide, iodide, formate, acetate, ascorbate, benzoate, carbonate, citrate, carbamate, formate, gluconate, lactate, methyl bromide, methyl sulfate, nitrate, phosphate, diphosphate, succinate, sulfate, and trifluoroacetate.

5. The method of claim 4 , wherein the nicotinamide riboside compound is a chloride salt.

6. The method of claim 3 , wherein the therapeutically effective amount of nicotinamide riboside compound, or a salt thereof, for a total dose is in a range of about 0.01% by weight to about 50% by weight based on the total weight of the composition; and wherein the wound repair is substantially effected.

Assignments (3)
CONFIDENTIALITY AGREEMENT Recorded Dec 21, 2017
From: DEREN-LEWIS, ANN
To: CHROMADEX INC.
Reel/Frame 044947/0233 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: RHONEMUS, TROY
To: CHROMADEX INC.
Reel/Frame 046246/0763 →
SECURITY INTEREST Recorded Nov 11, 2016
From: CHROMADEX, INC.
To: WESTERN ALLIANCE BANK
Reel/Frame 040291/0873 →